| Item Type | Name |
|
Concept
|
Head and Neck Neoplasms
|
|
Academic Article
|
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
|
|
Academic Article
|
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
|
|
Academic Article
|
In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
|
|
Academic Article
|
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials.
|
|
Academic Article
|
Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study.
|
|
Academic Article
|
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.
|
|
Academic Article
|
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial.
|
|
Academic Article
|
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
|
|
Academic Article
|
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
|
|
Academic Article
|
Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups.
|
|
Academic Article
|
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
|
|
Academic Article
|
Treatment of head and neck cancer.
|
|
Academic Article
|
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
|
|
Academic Article
|
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
|
|
Academic Article
|
Hyperfractionated or accelerated radiotherapy for head and neck cancer.
|
|
Academic Article
|
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
|
|
Academic Article
|
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
|
|
Academic Article
|
Bleomycin (NSC-125066) therapy of responsive solid tumors.
|
|
Academic Article
|
Radiation Therapy Oncology Group (RTOG) trials for head and neck cancer.
|
|
Academic Article
|
Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report.
|
|
Academic Article
|
Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
|
|
Academic Article
|
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.
|
|
Academic Article
|
Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
|
|
Academic Article
|
Mixed neutron/photon irradiation of unresectable squamous cell carcinomas of the head and neck: the final report of a randomized cooperative trial.
|
|
Academic Article
|
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
|
|
Academic Article
|
Evaluation of a neutron boost in head and neck cancer. Results of the randomized RTOG trial 78-08.
|
|
Academic Article
|
Workshop report: organ preservation strategies in advanced head and neck cancer--current status and future directions.
|
|
Academic Article
|
Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
|
|
Academic Article
|
Statistical response to Dr. J. M. Brown, IJROBP 32:883-885; 1995.
|
|
Academic Article
|
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
|
|
Academic Article
|
Lung cancer as a second primary.
|
|
Academic Article
|
Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry.
|
|
Academic Article
|
Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer Committee.
|
|
Academic Article
|
Chemotherapy following surgery for head and neck cancer. A Radiation Therapy Oncology Group Study.
|
|
Academic Article
|
Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group.
|
|
Academic Article
|
A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
|
|
Academic Article
|
Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer.
|
|
Academic Article
|
Failure of cricopharyngeal myotomy to improve dysphagia following head and neck cancer surgery.
|
|
Academic Article
|
Radiation therapy alone or in combination with surgery in head and neck cancer.
|
|
Academic Article
|
Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.
|
|
Academic Article
|
Induction chemotherapy in advanced head and neck cancer. A Radiation Therapy Oncology Group Study.
|
|
Academic Article
|
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
|
|
Academic Article
|
5-year results of cisplatin and fluorouracil infusion in head and neck cancer.
|
|
Academic Article
|
Development of surgical quality-control mechanisms in large-scale prospective trials: head and neck intergroup report.
|
|
Academic Article
|
Prognostic factors for loco/regional control and metastasis and the impact on survival.
|
|
Academic Article
|
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
|
|
Academic Article
|
Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial.
|
|
Academic Article
|
Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.
|
|
Academic Article
|
Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17.
|
|
Academic Article
|
Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?
|
|
Academic Article
|
Chemotherapy as predictor of compliance.
|
|
Academic Article
|
Impact of initial quality control review on study outcome in lung and head/neck cancer studies--review of the Radiation Therapy Oncology Group experience.
|
|
Academic Article
|
Combined therapy for resectable head and neck cancer. A phase 3 intergroup study.
|
|
Academic Article
|
Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
|
|
Academic Article
|
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study.
|
|
Academic Article
|
Analysis of neutron radiotherapy treatment complications.
|
|
Academic Article
|
Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer.
|
|
Academic Article
|
Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.
|
|
Academic Article
|
Surgical quality control in head and neck cancer. Study 73-03 of the Radiation Therapy Oncology Group.
|
|
Academic Article
|
Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. An RTOG study of 114 advanced stage tumors.
|